Session Details

Advanced Practice Professionals (APP track) Session 1 – Cord-Blood Derived Therapies for Regenerative Medicine, Transplantation & Cancer Immunotherapy
Thursday, May 30, 2019 11:00 AM - 12:15 PM 
Room 217
Advanced Practice Professionals Track
Megan Cornelison, MS, PA-C, MD Anderson Cancer Center, USA
Tobi Fisher, MPAS, PA-C, MD Anderson Cancer Center, USA

This session will discuss the benefits of cord blood transplantation and ex vivo expansion in allotransplantation, and the novel use of cord-blood derived iPSCs (immunologic Pluripotent stem cells).  We will also be discussing CAR T-cell and gene therapy development and manufacturing.

Cord Blood Transplantation for Hematologic Malignancies: Do We Need Expansion?
Juliet Barker, MBBS, Memorial Sloan Kettering Cancer Center, United States

Generating GMP-grade iPSCs from Banked Cord Blood for Potential Regenerative Therapy Purposes
Ngaire Elwood, PhD, Murdoch Children's Research Institute, Australia

CAR-T Cell and Gene Therapy Development and Manufacturing
David DiGiusto, PhD, Semma Therapeutics, United States

Megan Cornelison MS, PA-C
Supervisor, Advanced Practice Providers
MD Anderson Cancer Center

Tobi Fisher MPAS, PA-C
Physician Assistant
MD Anderson Cancer Center

Juliet Barker MBBS, FRACP
Attending Physician
Memorial Sloan Kettering Cancer Center

David DiGiusto PhD
Chief Technology Officer
Semma Therapeutics

Ngaire Elwood PhD
Director, BMDI Cord Blood Bank & Head Cord Blood Stem Cell Research Program
Murdoch Children's Research Institute